Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FRXTE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,312
Award facts
- Contract value 100% obligated
- $40,312.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $40,312.27. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is set for ultimate completion by May 23, 2025, and performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal contracts with the Defense Logistics Agency covering diverse pharmaceutical products and medical supplies used across military and veteran healthcare systems. The company's federal contract awards demonstrate capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Myrbetriq supply order reflects the company's role as a critical vendor within the DLA's pharmaceutical supply chain, supporting medical requirements for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FRXTE?
SPE2DB25FRXTE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 22, 2025.
How much is contract SPE2DB25FRXTE worth?
The government has obligated $40,312 on SPE2DB25FRXTE.
Is contract SPE2DB25FRXTE an order under another contract?
Yes. SPE2DB25FRXTE is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRXTE competed?
The extent of competition for SPE2DB25FRXTE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award